These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7985035)

  • 1. Gastrointestinal manifestations of systemic sclerosis.
    Abu-Shakra M; Guillemin F; Lee P
    Semin Arthritis Rheum; 1994 Aug; 24(1):29-39. PubMed ID: 7985035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
    Arif T; Masood Q; Singh J; Hassan I
    BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal involvement in patients with systemic sclerosis.
    Wielosz E; Borys O; Zychowska I; Majdan M
    Pol Arch Med Wewn; 2010 Apr; 120(4):132-6. PubMed ID: 20424538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastrointestinal involvement in systemic sclerosis].
    Marie I
    Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry.
    Luciano L; Granel B; Bernit E; Harle JR; Baumstarck K; Grimaud JC; Bouvier M; Vitton V
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):63-69. PubMed ID: 27243115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal motility disorder assessment in systemic sclerosis.
    Savarino E; Mei F; Parodi A; Ghio M; Furnari M; Gentile A; Berdini M; Di Sario A; Bendia E; Bonazzi P; Scarpellini E; Laterza L; Savarino V; Gasbarrini A
    Rheumatology (Oxford); 2013 Jun; 52(6):1095-100. PubMed ID: 23382360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis.
    Bae S; Allanore Y; Furst DE; Bodukam V; Coustet B; Morgaceva O; Maranian P; Khanna D
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):57-63. PubMed ID: 23910611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity.
    Raja J; Ng CT; Sujau I; Chin KF; Sockalingam S
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):115-121. PubMed ID: 26843456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality.
    Horsley-Silva JL; Umar SB; Vela MF; Griffing WL; Parish JM; DiBaise JK; Crowell MD
    Dis Esophagus; 2019 May; 32(5):. PubMed ID: 30715227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
    Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
    Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis.
    Yang H; Xu D; Li MT; Yao Y; Jin M; Zeng XF; Qian JM
    J Dig Dis; 2019 May; 20(5):256-261. PubMed ID: 30838807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders.
    Weston S; Thumshirn M; Wiste J; Camilleri M
    Am J Gastroenterol; 1998 Jul; 93(7):1085-9. PubMed ID: 9672335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastrointestinal features in systemic sclerosis].
    Stelle M; Chizzolini C
    Rev Med Suisse; 2014 Apr; 10(426):860-3. PubMed ID: 24834644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal manifestations in Hungarian scleroderma patients.
    Szamosi S; Szekanecz Z; Szucs G
    Rheumatol Int; 2006 Oct; 26(12):1120-4. PubMed ID: 16770615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early endoscopy in systemic sclerosis without gastrointestinal symptoms.
    Thonhofer R; Siegel C; Trummer M; Graninger W
    Rheumatol Int; 2012 Jan; 32(1):165-8. PubMed ID: 20711592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review.
    Schutyser W; Cruyt L; Vulsteke JB; Lenaerts JL; De Langhe E
    Clin Rheumatol; 2020 Jan; 39(1):149-157. PubMed ID: 31709478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.
    Abozaid HSM; Imam HMK; Abdelaziz MM; El-Hammady DH; Fathi NA; Furst DE
    Semin Arthritis Rheum; 2017 Dec; 47(3):403-408. PubMed ID: 28624173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis.
    Omair MA; Lee P
    J Rheumatol; 2012 May; 39(5):992-6. PubMed ID: 22467930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride.
    Boeckxstaens GE; Bartelsman JF; Lauwers L; Tytgat GN
    Am J Gastroenterol; 2002 Jan; 97(1):194-7. PubMed ID: 11811166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.